ARCHIVES

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

OMB Budget Revision Would Cut Centers $20 Million, Slash Clinical Education, Training, Contracts Funds

April 22, 1983

Watson To Head Genome Research

September 30, 1988

Commentary: NCI’s Budge Proposal ForFY2001 Offers A Blueprint for Research

November 26, 1999

NIH Grants: R29 Awards No Longer Accepted After June; NIH To Increase R01s.

December 5, 1997

Carlson Named NCCN Chief Executive

September 28, 2012

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

June 24, 2005